林森生物 (873016.OC)

+ 收藏

资产负债表(林森生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表
流动资产:
 货币资金(元) 332,110.791,192,410.589,940,763.894,502,266.00
 应收票据及应收账款(元) 36,192,486.5430,084,887.8932,562,526.0737,833,428.54
  其中:应收票据(元) 644,300.00---
  其中:应收账款(元) 35,548,186.5430,084,887.8932,562,526.0737,833,428.54
 预付款项(元) 21,949,129.3813,206,897.1617,863,978.526,179,289.90
 其他应收款(元) 519,709.341,302,185.16737,884.462,008,323.72
 存货(元) 66,097,571.4171,254,924.9876,930,887.8260,201,527.95
 其他流动资产(元) 351,642.99528,956.43117,343.2438,521.64
 流动资产合计(元) 125,442,650.45117,570,262.20138,153,384.00110,763,357.75
非流动资产:
 固定资产(元) 19,215,322.5518,453,940.4519,177,287.3720,185,901.10
 在建工程(元) -1,129,722.331,129,722.33309,000.00
 使用权资产(元) 1,122,169.481,269,512.851,418,078.841,547,973.45
 无形资产(元) 63,000.2477,000.2291,000.20105,000.18
 长期待摊费用(元) 338,000.00---
 递延所得税资产(元) 1,791,483.63735,870.16758,539.73640,932.82
 其他非流动资产(元) 767,520.001,024,630.001,433,520.00532,650.00
 非流动资产合计(元) 23,297,495.9022,690,676.0124,008,148.4723,321,457.55
资产总计(元) 148,740,146.35140,260,938.21162,161,532.47134,084,815.30
流动负债:
 短期借款(元) 3,000,000.006,500,000.005,400,000.006,151,000.00
 应付票据及应付账款(元) 77,308,532.4771,946,270.6383,747,460.7743,725,784.59
  其中:应付账款(元) 77,308,532.4771,946,270.6383,747,460.7743,725,784.59
 合同负债(元) 14,272,525.6910,781,570.6413,916,329.496,401,876.56
 应付职工薪酬(元) 233,592.50240,605.01240,605.01267,105.01
 应交税费(元) 2,038,893.13337,453.462,202,782.33470,719.40
 其他应付款(元) 12,537,286.5110,859,955.7615,185,660.1342,516,106.22
 一年内到期的非流动负债(元) 120,912.87303,886.58760,359.92677,904.77
 其他流动负债(元) 1,608,808.08880,431.54812,019.44435,269.83
 流动负债合计(元) 111,120,551.25101,850,173.62122,265,217.09100,645,766.38
非流动负债:
 长期借款(元) 3,500,000.00--511,177.27
 租赁负债(元) 846,462.20547,125.39867,758.99807,957.12
 递延收益(元) 5,666,666.705,866,666.706,066,666.706,266,666.70
 非流动负债合计(元) 10,013,128.906,413,792.096,934,425.697,585,801.09
负债合计(元) 121,133,680.15108,263,965.71129,199,642.78108,231,567.47
所有者权益(或股东权益):
 实收资本或股本(元) 24,000,000.0024,000,000.0024,000,000.0010,000,000.00
 资本公积(元) 1,786,312.301,736,312.301,686,312.305,624,407.60
 盈余公积(元) 1,765,035.751,765,035.751,765,035.75-
 未分配利润(元) 55,118.154,495,624.455,510,541.6410,228,840.23
 归属于母公司股东权益合计(元) 27,606,466.2031,996,972.5032,961,889.6925,853,247.83
 股东权益合计(元) 27,606,466.2031,996,972.5032,961,889.6925,853,247.83
负债和股东权益合计(元) 148,740,146.35140,260,938.21162,161,532.47134,084,815.30
公告日期 2024-04-262023-08-292023-03-272022-08-29
审计意见(境内) 带强调事项段的无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院